-
Acupuncture with Planning Treatment According to Diagnosis: A Trial Study of Protocol and its Effects for Stiff Shoulder
Wenping Zhang, Atushi Takeda, Kaito Mizuno, Masayuki Kanehara, Ken Takagi, Ryohei Ishiyama, Shigeru Urata, Ko Nishimura
Commentary: Clinical Investigation
-
Acupuncture with Planning Treatment According to Diagnosis: A Trial Study of Protocol and its Effects for Stiff Shoulder
Wenping Zhang, Atushi Takeda, Kaito Mizuno, Masayuki Kanehara, Ken Takagi, Ryohei Ishiyama, Shigeru Urata, Ko Nishimura
Commentary: Clinical Investigation
-
Acupuncture with Planning Treatment According to Diagnosis: A Trial Study of Protocol and its Effects for Stiff Shoulder
Wenping Zhang, Atushi Takeda, Kaito Mizuno, Masayuki Kanehara, Ken Takagi, Ryohei Ishiyama, Shigeru Urata, Ko Nishimura
Commentary: Clinical Investigation
-
Acupuncture with Planning Treatment According to Diagnosis: A Trial Study of Protocol and its Effects for Stiff Shoulder
Wenping Zhang, Atushi Takeda, Kaito Mizuno, Masayuki Kanehara, Ken Takagi, Ryohei Ishiyama, Shigeru Urata, Ko Nishimura
Commentary: Clinical Investigation
-
Acupuncture with Planning Treatment According to Diagnosis: A Trial Study of Protocol and its Effects for Stiff Shoulder
Wenping Zhang, Atushi Takeda, Kaito Mizuno, Masayuki Kanehara, Ken Takagi, Ryohei Ishiyama, Shigeru Urata, Ko Nishimura
Commentary: Clinical Investigation
-
Acupuncture with Planning Treatment According to Diagnosis: A Trial Study of Protocol and its Effects for Stiff Shoulder
Wenping Zhang, Atushi Takeda, Kaito Mizuno, Masayuki Kanehara, Ken Takagi, Ryohei Ishiyama, Shigeru Urata, Ko Nishimura
Commentary: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
Bevacizumab in the treatment of epithelial ovarian carcinoma
Brittany A Davidson & Angeles Alvarez Secord
Review: Clinical Trail Outcomes: Clinical Investigation
-
Bevacizumab in the treatment of epithelial ovarian carcinoma
Brittany A Davidson & Angeles Alvarez Secord
Review: Clinical Trail Outcomes: Clinical Investigation
-
Bevacizumab in the treatment of epithelial ovarian carcinoma
Brittany A Davidson & Angeles Alvarez Secord
Review: Clinical Trail Outcomes: Clinical Investigation
-
Bevacizumab in the treatment of epithelial ovarian carcinoma
Brittany A Davidson & Angeles Alvarez Secord
Review: Clinical Trail Outcomes: Clinical Investigation
-
Bevacizumab in the treatment of epithelial ovarian carcinoma
Brittany A Davidson & Angeles Alvarez Secord
Review: Clinical Trail Outcomes: Clinical Investigation
-
Bevacizumab in the treatment of epithelial ovarian carcinoma
Brittany A Davidson & Angeles Alvarez Secord
Review: Clinical Trail Outcomes: Clinical Investigation
-
Concept, characteristics and implications of cluster randomization
Monica Taljaard, Jeremy M Grimshaw
Editorial: Clinical Investigation
-
Concept, characteristics and implications of cluster randomization
Monica Taljaard, Jeremy M Grimshaw
Editorial: Clinical Investigation
-
Concept, characteristics and implications of cluster randomization
Monica Taljaard, Jeremy M Grimshaw
Editorial: Clinical Investigation
-
Concept, characteristics and implications of cluster randomization
Monica Taljaard, Jeremy M Grimshaw
Editorial: Clinical Investigation
-
Concept, characteristics and implications of cluster randomization
Monica Taljaard, Jeremy M Grimshaw
Editorial: Clinical Investigation
-
Concept, characteristics and implications of cluster randomization
Monica Taljaard, Jeremy M Grimshaw
Editorial: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
New developments in the diagnosis and treatment of von Willebrand disease
Emmanuel J Favaloro
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of von Willebrand disease
Emmanuel J Favaloro
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of von Willebrand disease
Emmanuel J Favaloro
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of von Willebrand disease
Emmanuel J Favaloro
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of von Willebrand disease
Emmanuel J Favaloro
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of von Willebrand disease
Emmanuel J Favaloro
Review: Clinical Trail Outcomes: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
Early-phase oncology clinical trial design in the era of molecularly targeted therapy: pitfalls and progress
Penelope Bradbury, John Hilton , Lesley Seymour
Review Article: Clinical Investigation
-
Early-phase oncology clinical trial design in the era of molecularly targeted therapy: pitfalls and progress
Penelope Bradbury, John Hilton , Lesley Seymour
Review Article: Clinical Investigation
-
Early-phase oncology clinical trial design in the era of molecularly targeted therapy: pitfalls and progress
Penelope Bradbury, John Hilton , Lesley Seymour
Review Article: Clinical Investigation
-
Early-phase oncology clinical trial design in the era of molecularly targeted therapy: pitfalls and progress
Penelope Bradbury, John Hilton , Lesley Seymour
Review Article: Clinical Investigation
-
Early-phase oncology clinical trial design in the era of molecularly targeted therapy: pitfalls and progress
Penelope Bradbury, John Hilton , Lesley Seymour
Review Article: Clinical Investigation
-
Early-phase oncology clinical trial design in the era of molecularly targeted therapy: pitfalls and progress
Penelope Bradbury, John Hilton , Lesley Seymour
Review Article: Clinical Investigation